Voya Financial Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,893
Closed -$1.01M 580
2021
Q1
$1.01M Sell
11,893
-259
-2% -$24.1K 0.04% 287
2020
Q4
$1.16M Hold
12,152
0.05% 247
2020
Q3
$1.37M Buy
12,152
+29
+0.2% +$3.05K 0.07% 217
2020
Q2
$1.06M Buy
12,123
+91
+0.8% +$7.26K 0.06% 238
2020
Q1
$818K Sell
12,032
-279
-2% -$19.5K 0.05% 260
2019
Q4
$724K Buy
12,311
+1,584
+15% +$97.7K 0.04% 326
2019
Q3
$631K Buy
10,727
+978
+10% +$62.4K 0.03% 335
2019
Q2
$613K Buy
9,749
+1,394
+17% +$90K 0.03% 346
2019
Q1
$533K Buy
8,355
+780
+10% +$41K 0.03% 358
2018
Q4
$283K Buy
+7,575
New +$267K 0.02% 442

Other funds holding TNDM

Voya Financial Advisors's TNDM Position: Q2 2021 in Review

Voya Financial Advisors sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 11,893 shares — an estimated $1.01M sold.

Voya Financial Advisors first reported a position in TNDM in Q4 2018 and held it in 10 quarters. The position peaked at $1.37M in Q3 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Voya Financial Advisors reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
  • Voya Financial Advisors sold 11,893 Tandem Diabetes Care shares in Q2 2021, an estimated $1.01M.
  • Voya Financial Advisors first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 10 quarters.
  • Voya Financial Advisors's Tandem Diabetes Care position peaked at $1.37M in Q3 2020.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Voya Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.